Cigna Investments’s Medifast MED Stock Holding History

Cigna Investments’s Portfolio MED Stock Details MED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-2,971	Closed	-$207K	–	866
2017 Q4	$207K	Buy	+2,971	New	+$197K	0.01%	836
2017 Q3	–	Sell	-5,769	Closed	-$241K	–	906
2017 Q2	$241K	Sell	5,769 -18,610	-76%	-$809K	0.02%	705
2017 Q1	$1.09M	Buy	24,379 +188	+0.8%	+$8.09K	0.07%	253
2016 Q4	$1.01M	Buy	+24,191	New	+$974K	0.11%	236

Other funds holding MED

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

MWNA

Marshall Wace North America New York $23.5B AUM 46.46% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Man Group London, United Kingdom $62.7B AUM 29.77% 1-Year Est. Return

Cigna Investments's MED Position: Q1 2018 in Review

Cigna Investments sold out of Medifast (MED) in Q1 2018, closing a stake of 2,971 shares — an estimated $207K sold.

Cigna Investments first reported a position in MED in Q4 2016 and held it in 4 quarters. The position peaked at $1.09M in Q1 2017. 225 funds tracked by Wall St. Rank hold MED as of Q1 2018.

Cigna Investments reported no remaining Medifast position as of Q1 2018 after selling out during the quarter.
Cigna Investments sold 2,971 Medifast shares in Q1 2018, an estimated $207K.
Cigna Investments first reported a position in Medifast in Q4 2016 and held it in 4 quarters.
Cigna Investments's Medifast position peaked at $1.09M in Q1 2017.
225 funds tracked by Wall St. Rank held Medifast as of Q1 2018.

Based on Cigna Investments's 13F filing for Q1 2018, filed 9 May 2018.